CORCEPT THERAPEUTICS INC (CORT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 90M 180M 270M Q4 '11: 0 Q1 '12: 0 Q1 '17: 27.6M Q2 '17: 35.6M Q3 '17: 42.8M Q4 '17: 53.3M Q1 '18: 57.7M Q2 '18: 62.3M Q3 '18: 64.4M Q4 '18: 66.8M Q1 '19: 64.8M Q2 '19: 72.3M Q3 '19: 81.5M Q4 '19: 87.9M Q1 '20: 93.2M Q2 '20: 88.6M Q3 '20: 86.3M Q4 '20: 85.7M Q1 '21: 79.4M Q2 '21: 91.6M Q3 '21: 96.1M Q4 '21: 98.8M Q1 '22: 93.7M Q2 '22: 103.4M Q3 '22: 101.7M Q4 '22: 103.1M Q1 '23: 105.7M Q2 '23: 117.7M Q3 '23: 123.6M Q4 '23: 135.4M Q1 '24: 146.8M Q2 '24: 163.8M Q3 '24: 182.5M Q4 '24: 181.9M Q1 '25: 157.2M Q2 '25: 194.4M Q3 '25: 207.6M Q4 '25: 202.1M Q1 '26: 164.9M Q2 '26: 256.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 35M 70M 105M Q2 '12: 827K Q3 '12: 1M Q4 '12: 1.4M Q1 '13: 1.7M Q2 '13: 1.9M Q3 '13: 2.6M Q4 '13: 4.1M Q1 '14: 4.2M Q2 '14: 5.6M Q3 '14: 7M Q4 '14: 8.8M Q1 '15: 9.8M Q2 '15: 11.5M Q3 '15: 13M Q4 '15: 14.6M Q1 '16: 15.7M Q2 '16: 19.3M Q3 '16: 21.1M Q4 '16: 23.2M Q1 '17: 27M Q2 '17: 34.8M Q3 '17: 41.8M Q4 '17: 52.1M Q1 '18: 56.5M Q2 '18: 61.2M Q3 '18: 63.1M Q4 '18: 65.3M Q1 '19: 63.6M Q2 '19: 70.9M Q3 '19: 80.1M Q4 '19: 86.5M Q1 '20: 91.4M Q2 '20: 87.3M Q3 '20: 85.1M Q4 '20: 84.5M Q2 '13 Q3 '14 Q4 '15 Q1 '17 Q2 '18 Q3 '19 Q4 '20

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '16: 3.1M Q4 '16: 5M Q1 '17: 4.7M Q2 '17: 12.8M Q3 '17: 13.6M Q4 '17: 21.7M Q1 '18: 21M Q2 '18: 20.6M Q3 '18: 23M Q4 '18: 24.9M Q1 '19: 19M Q2 '19: 24.6M Q3 '19: 33M Q4 '19: 35M Q1 '20: 37.7M Q2 '20: 35.3M Q3 '20: 24.7M Q4 '20: 30.5M Q1 '21: 19.6M Q2 '21: 31.9M Q3 '21: 36.2M Q4 '21: 36.7M Q1 '22: 26.8M Q2 '22: 31.4M Q3 '22: 31.9M Q4 '22: 22.5M Q1 '23: 14.9M Q2 '23: 29.6M Q3 '23: 31.2M Q4 '23: 31.7M Q1 '24: 29.5M Q2 '24: 35.6M Q3 '24: 46.6M Q4 '24: 25.3M Q1 '25: 3.4M Q2 '25: 26.7M Q3 '25: 10.2M Q4 '25: 4.5M Q1 '26: -49.6M Q2 '26: 41.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-35M 0 35M 70M 105M Q3 '16: 2.6M Q4 '16: 4.6M Q1 '17: 4.4M Q2 '17: 12.6M Q3 '17: 13.8M Q4 '17: 98.3M Q1 '18: 17.5M Q2 '18: 18.2M Q3 '18: 17.7M Q4 '18: 22M Q1 '19: 18.3M Q2 '19: 20.2M Q3 '19: 26.3M Q4 '19: 29.4M Q1 '20: 30.1M Q2 '20: 28.3M Q3 '20: 21.6M Q4 '20: 26M Q1 '21: 23.5M Q2 '21: 26.5M Q3 '21: 30.5M Q4 '21: 32.1M Q1 '22: 22.8M Q2 '22: 27.4M Q3 '22: 34.6M Q4 '22: 16.6M Q1 '23: 15.9M Q2 '23: 27.5M Q3 '23: 31.4M Q4 '23: 31.4M Q1 '24: 27.8M Q2 '24: 35.5M Q3 '24: 47.2M Q4 '24: 30.7M Q1 '25: 20.5M Q2 '25: 35.1M Q3 '25: 19.7M Q4 '25: 24.3M Q1 '26: -31.8M Q2 '26: 43M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 2M 4M 6M Q3 '15: 256K Q4 '15: 364K Q1 '17: 646K Q2 '17: 775K Q3 '17: 976K Q4 '17: 1.2M Q1 '18: 1.2M Q2 '18: 1.2M Q3 '18: 1.3M Q4 '18: 1.6M Q1 '19: 1.2M Q2 '19: 1.4M Q3 '19: 1.5M Q4 '19: 1.4M Q1 '20: 1.9M Q2 '20: 1.2M Q3 '20: 1.2M Q4 '20: 1.3M Q1 '21: 1.3M Q2 '21: 1.4M Q3 '21: 1.3M Q4 '21: 1.4M Q1 '22: 1.2M Q2 '22: 1.3M Q3 '22: 1.3M Q4 '22: 1.5M Q1 '23: 1.4M Q2 '23: 1.6M Q3 '23: 1.6M Q4 '23: 1.9M Q1 '24: 2.5M Q2 '24: 2.5M Q3 '24: 2.9M Q4 '24: 3M Q1 '25: 2.4M Q2 '25: 3.4M Q3 '25: 4.6M Q4 '25: 2.5M Q1 '26: 2.9M Q2 '26: 4.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-25M 0 25M 50M 75M Q3 '16: 8.9M Q4 '16: 4.6M Q1 '17: 9.6M Q2 '17: 15.6M Q3 '17: 10.9M Q4 '17: 24.9M Q1 '18: 34.4M Q2 '18: 15.2M Q3 '18: 44.5M Q4 '18: 21.5M Q1 '19: 23.7M Q2 '19: 25.6M Q3 '19: 38.4M Q4 '19: 48.5M Q1 '20: 33.3M Q2 '20: 53.2M Q3 '20: 30.4M Q4 '20: 35.1M Q1 '21: 25.4M Q2 '21: 44.3M Q3 '21: 48.7M Q4 '21: 49.4M Q1 '22: 35.2M Q2 '22: 18M Q3 '22: 33.6M Q4 '22: 33.4M Q1 '23: 26M Q2 '23: 42.3M Q3 '23: 52.9M Q4 '23: 5.5M Q1 '24: 23.8M Q2 '24: 41.2M Q3 '24: 73.3M Q4 '24: 60.1M Q1 '25: 4.8M Q2 '25: 44.3M Q3 '25: 54.5M Q4 '25: 38.4M Q1 '26: -16.8M Q2 '26: 33.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-25M 0 25M 50M 75M Q3 '16: 8.8M Q4 '16: 4.5M Q1 '17: 9.5M Q2 '17: 15.4M Q3 '17: 10.8M Q4 '17: 24.9M Q1 '18: 34.4M Q2 '18: 15.1M Q3 '18: 44.5M Q4 '18: 21.4M Q1 '19: 23.4M Q2 '19: 25.1M Q3 '19: 38.1M Q4 '19: 48.3M Q1 '20: 33.2M Q2 '20: 53.1M Q3 '20: 29.7M Q4 '20: 34.6M Q1 '21: 25.3M Q2 '21: 44.2M Q3 '21: 48.5M Q4 '21: 49.4M Q1 '22: 35.2M Q2 '22: 18M Q3 '22: 33.3M Q4 '22: 33.4M Q1 '23: 26M Q2 '23: 42.2M Q3 '23: 52.9M Q4 '23: 5.5M Q1 '24: 23.8M Q2 '24: 40.8M Q3 '24: 71.7M Q4 '24: 59.9M Q1 '25: 4.7M Q2 '25: 44.2M Q3 '25: 54.5M Q4 '25: 38.4M Q1 '26: -17M Q2 '26: 31M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q2 '15: 107.9M Q3 '15: 108.5M Q1 '16: 109.7M Q2 '16: 115.3M Q3 '16: 116.4M Q1 '17: 121.2M Q2 '17: 123M Q3 '17: 125.7M Q1 '18: 127.7M Q2 '18: 127.5M Q3 '18: 126.2M Q1 '19: 123.9M Q2 '19: 121.8M Q3 '19: 121.8M Q1 '20: 122.2M Q2 '20: 123.2M Q3 '20: 124.5M Q1 '21: 129.7M Q2 '21: 126.7M Q3 '21: 125.1M Q1 '22: 115M Q2 '22: 115.4M Q3 '22: 116.6M Q1 '23: 115.4M Q2 '23: 109.6M Q3 '23: 111.1M Q1 '24: 109.9M Q2 '24: 111.2M Q3 '24: 113.7M Q1 '25: 119.8M Q2 '25: 120.5M Q3 '25: 119.4M Q1 '26: 104.4M Q2 '26: 118.4M Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.50 1.00 1.50 Q3 '16: 0.04 Q4 '16: 0.07 Q1 '17: 0.11 Q2 '17: 0.20 Q3 '17: 0.29 Q4 '17: 1.02 Q1 '18: 1.12 Q2 '18: 1.16 Q3 '18: 1.19 Q4 '18: 0.60 Q1 '19: 0.61 Q2 '19: 0.64 Q3 '19: 0.72 Q4 '19: 0.78 Q1 '20: 0.88 Q2 '20: 0.94 Q3 '20: 0.89 Q4 '20: 0.85 Q1 '21: 0.78 Q2 '21: 0.76 Q3 '21: 0.83 Q4 '21: 0.89 Q1 '22: 0.91 Q2 '22: 0.94 Q3 '22: 1.00 Q4 '22: 0.88 Q1 '23: 0.82 Q2 '23: 0.83 Q3 '23: 0.81 Q4 '23: 0.95 Q1 '24: 1.06 Q2 '24: 1.13 Q3 '24: 1.26 Q4 '24: 1.23 Q1 '25: 1.15 Q2 '25: 1.12 Q3 '25: 0.87 Q4 '25: 0.82 Q1 '26: 0.35 Q2 '26: 0.42 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.